Holland & Knight advised Savara on the offering. Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, announced a $100 million...
Savara’s $100 Million Common Stock Offering
Advanced MedAesthetic Partners’ Partnership with Blush Med Spa
Holland & Knight advised Advanced MedAesthetic Partners on the deal. Advanced MedAesthetic Partners (AMP) announced its new alliance with Blush Med Spa, a medical aesthetics practice...
Advanced MedAesthetic Partners’ Investment in Destination Aesthetics
Holland & Knight advised Advanced MedAesthetic Partners on the deal. Advanced MedAesthetic Partners announced its strategic investment in Destination Aesthetics. The deal was announced on March 17,...
Lincoln Road Global Management’s Acquisition of Zodega
Holland & Knight advised Lincoln Road Global Management, LLC on the deal. Lincoln Road Global Management, LLC announced its acquisition of Zodega, a provider of full-service...
Sanofi’s Pending Acquisition of Amunix
Fenwick & West advised Amunix on the deal, while Weil, Gotshal & Manges advised Sanofi. Amunix, an immuno-oncology company, announced its pending acquisition by Sanofi, a global...
Sanofi’s $1.9 Billion Acquisition of Kadmon
Weil, Gotshal & Manges represented Sanofi in the transaction. Sanofi, a global biopharmaceutical company focused on human health, executed its $1.9 billion acquisition of Kadmon Holdings, Inc.,...
VICI Properties, Inc.’s US$17.2 Billion Acquisition Of MGM Growth Properties
Hogan Lovells and Kramer Levin advised VICI Properties, Inc. on the deal. Sullivan & Cromwell represented the Lenders. Baker Botts represented MGM Growth Properties. Weil, Gotshal...